Visalytics
Visalytics
approved EB-2 (NIW)

Pharmaceutical Scientist

Public Health · China · 2025-01-10

Processing Time
42 days
Decision Date
2025-01-10
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research in the field of public health, specifically focusing on pharmaceutical science to address global healthcare challenges. His work aims to mitigate resource shortages and reduce the burden of adverse drug reactions through computational science and engineering methodologies. The intended impact is to advance global healthcare outcomes and improve the safety and efficiency of the healthcare system.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The work addresses key healthcare challenges including resource shortages and adverse drug reactions, which are vital to global public health outcomes.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to his M.S. degree, 5 peer-reviewed journal articles, and 34 citations demonstrating influence on his peers.

3 Waiver of Job Offer and Labor Certification Met

Based on his recognized expertise and the 13 reviews completed, it was determined beneficial to the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.S. in computational science and engineering and his record of 5 peer-reviewed journal articles and 1 letter to the editor. He demonstrated significant influence in the field with 34 citations and a publication in a journal with an impact factor of 5.0. Additionally, his expertise was validated by 13 peer-review invitations, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Original Contributions

Similar Cases

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Illinois 110 days 2023-02-02
The petitioner proposes to conduct research combining pharmacoepidemiology, pharmacoeconomics, and health outcomes science to identify treatment risks and prescribing patterns. Her work focuses on uncovering disease mechanisms and patient outcomes in chronic conditions like COPD, liver disease, and breast cancer to inform better diagnostic and therapeutic strategies. The endeavor aims to improve healthcare delivery efficiency and public health innovation within the United States.
View Case

Research Assistant

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
California 426 days 2025-01-08
The petitioner proposes to continue research in pharmaceutical chemistry with a focus on drug discovery optimization and the development of advanced computational techniques. This work involves identifying new therapeutics for human diseases and creating computational methods that offer significant advantages over conventional drug discovery approaches. The intended impact is to reduce the economic and social costs of disease while improving global public health.
View Case

Consultant

Engineering · India

WeGreened EB-2 (NIW) approved
New Jersey 45 days 2025-01-16
The petitioner proposes to continue research on developing advanced machine learning, artificial intelligence, and language modeling frameworks by integrating data-driven methods with domain knowledge. This work aims to address key challenges in drug development and healthcare, specifically focusing on accelerating drug discovery, optimizing clinical trials, and enhancing manufacturing efficiency.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-10.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 42 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist